| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Milestone Pharmaceuticals Inc. (MIST) has 13 insiders with recent SEC Form 4 filings, including 6 buys and 12 sells. MIST is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 679.0K | $1.31M | - | |
| COO | 204.0K | $392.7K | - | |
| Other | 204.0K | $392.7K | - | |
| CFO | 204.0K | $392.7K | - | |
| Other | 204.0K | $392.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Bharucha David | Chief Medical Officer | Sale+OE | 70,252 | $2.25 | $158,209.09 | -24.3% | - | - | |
| Jan 26, 2026 | Nelson Jeffrey Edward | Chief Operating Officer | Sale+OE | 70,252 | $2.25 | $158,209.09 | -43.3% | - | - | |
| Jan 26, 2026 | Muller Lorenz | Chief Commercial Officer | Sale+OE | 64,746 | $2.25 | $145,850.52 | -13.9% | - | - | |
| Jan 26, 2026 | Hasija Amit | CFO &EVP Of Corp. Development | Sale+OE | 70,252 | $2.25 | $158,209.09 | -26.8% | - | - | |
| Jan 26, 2026 | Oliveto Joseph59 | President And CEO | Sale+OE | 167,577 | $2.24 | $375,314.67 | -15.2% | - | - | |
| Jan 8, 2026 | Oliveto Joseph59 | President And CEO | Sell | 43,500 | $2.25 | $97,875.00 | -6.3% | -18.7% | - | |
| Dec 5, 2022 | Bharucha David | Chief Medical Officer | Buy | 10,000 | $4.74 | $47,410.00 | +333.3% | -24.6% | -32.0% | |
| Oct 21, 2022 | Liebert Debra K. | Director | Buy | 14,000 | $5.28 | $73,940.00 | New | -26.6% | -47.0% | |
| Oct 20, 2022 | Pasternak Richard C | Director | Buy | 10,000 | $5.20 | $52,000.00 | New | -27.5% | -48.2% | |
| Oct 19, 2022 | Tomsicek Michael John | Director | Buy | 15,000 | $5.32 | $79,800.00 | New | -21.0% | -44.6% |